Algert Global LLC Durect Corp Transaction History

Algert Global LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.38 - $0.64 $13,163 - $22,169	34,640 New	34,640 $17,000
Q4 2020 Feb 12, 2021	SELL	$1.65 - $2.43 $44,682 - $65,804	-27,080 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.6 - $2.35 $43,328 - $63,638	27,080 New	27,080 $46,000
Q3 2018 Nov 14, 2018	SELL	$1.06 - $1.69 $160,934 - $256,584	-151,825 Closed	0 $0
Q2 2018 Aug 02, 2018	SELL	$1.56 - $2.51 $541,142 - $870,683	-346,886 Reduced 69.56%	151,825 $237,000
Q1 2018 May 03, 2018	BUY	$0.91 - $2.24 $350,430 - $862,597	385,088 Added 338.92%	498,711 $1.07 Million
Q4 2017 Feb 01, 2018	BUY	$0.78 - $2.1 $88,625 - $238,608	113,623	113,623 $105,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $171M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.